Your browser doesn't support javascript.
loading
Autoimmune phenomena as prognostic markers of response to adjuvant interferon therapy for melanoma
Puente Vázquez, J; González Larriba, JL.
Affiliation
  • Puente Vázquez, J; s.af
  • González Larriba, JL; s.af
Clin. transl. oncol. (Print) ; 9(3): 125-126, mar. 2007.
Article in En | IBECS | ID: ibc-123280
Responsible library: ES1.1
Localization: BNCS
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Autoimmunity / Randomized Controlled Trials as Topic / Purpura, Thrombocytopenic, Idiopathic / Interferon-alpha / Chemotherapy, Adjuvant / Clinical Trials, Phase III as Topic / Melanoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin. transl. oncol. (Print) Year: 2007 Document type: Article
Search on Google
Collection: 06-national / ES Database: IBECS Main subject: Autoimmunity / Randomized Controlled Trials as Topic / Purpura, Thrombocytopenic, Idiopathic / Interferon-alpha / Chemotherapy, Adjuvant / Clinical Trials, Phase III as Topic / Melanoma Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin. transl. oncol. (Print) Year: 2007 Document type: Article